Met Life Investment Management, LLC Alector, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 5,468 shares of ALEC stock, worth $10,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,468
Previous 50,369
89.14%
Holding current value
$10,225
Previous $235,000
95.74%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ALEC
# of Institutions
155Shares Held
55MCall Options Held
39.7KPut Options Held
51K-
Ra Capital Management, L.P. Boston, MA9.7MShares$18.1 Million0.3% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$10.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.91MShares$3.58 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$3.46 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $154M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...